Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors.
about
New viruses for cancer therapy: meeting clinical needsRetargeting Strategies for Oncolytic Herpes Simplex VirusesBacteriophage-derived vectors for targeted cancer gene therapyCo-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions.HSV-1 Cgal+ infection promotes quaking RNA binding protein production and induces nuclear-cytoplasmic shuttling of quaking I-5 isoform in human hepatoma cells.Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodentsPotent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft modelsOncolytic virotherapyKilling of cancer cells through the use of eukaryotic expression vectors harbouring genes encoding nucleases and ribonuclease inhibitor.A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression.Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging.Oncolytic virotherapy in upper gastrointestinal tract cancers.MicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular Carcinoma
P2860
Q24567699-3D620287-1A1B-41F9-BB90-E8A6558EEDF7Q26765439-BCD77495-5243-48F8-AEFA-CCA8C1E7FCD8Q26865726-BA9DF2C9-1876-411C-88CE-76E0D442C49BQ34554049-769B5B65-05AE-4AF1-941D-0009754393AEQ35026933-97C2C79D-B206-4FA1-A074-14EA782C5213Q35155806-BA68A032-A077-4B52-B029-1C5617D3F26EQ37031733-309EEEC5-1752-4EE6-A4D7-3C0E53570A3AQ38025263-77F10094-8300-40C7-A2B1-66165F95D39EQ38421345-496C934B-220F-41AC-B025-D996EFC55D19Q39005729-03C9E864-AFE6-4496-B76A-FBE8EAA71303Q39122342-E5BCE542-4292-4C62-9F58-38DB3921B35AQ39473687-4B97C2A9-7822-4143-9BA1-DD1BBEBAA57DQ54242367-0E4F001C-E7A5-41A0-9D69-C6E42F34F097Q58704496-32950D9E-461D-4218-A0CA-DD93F72CDA51
P2860
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Novel tumour-specific promoter ...... herpes simplex virus vectors.
@en
Novel tumour-specific promoter ...... herpes simplex virus vectors.
@nl
type
label
Novel tumour-specific promoter ...... herpes simplex virus vectors.
@en
Novel tumour-specific promoter ...... herpes simplex virus vectors.
@nl
prefLabel
Novel tumour-specific promoter ...... herpes simplex virus vectors.
@en
Novel tumour-specific promoter ...... herpes simplex virus vectors.
@nl
P2093
P356
P1476
Novel tumour-specific promoter ...... herpes simplex virus vectors.
@en
P2093
Alberto L Epstein
Aldo Pourchet
Dorothea Kazazi
George Pissas
Georgia Dalagiorgou
John Koskinas
Manousos M Konstadoulakis
Mariagiovanna Foschini
Pelagia Foka
Penelope Mavromara
P2860
P304
P356
10.1002/JGM.1519
P577
2010-12-01T00:00:00Z